本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Immunovant, Inc.

15.20
-1.8900-11.06%
盤後15.10-0.1000-0.66%19:58 EDT
成交量:371.15萬
成交額:5,809.54萬
市值:25.82億
市盈率:-5.81
高:17.09
開:17.06
低:15.00
收:17.09
資料載入中...

公司資料

公司名字:
Immunovant, Inc.
交易所:
NASDAQ
成立時間:
- -
員工人數:
207
公司地址:
320 West 37th Street,6th Floor,New York,New York,United States
郵編:
10018
電話:
傳真:
- -
簡介:
Immunovant, Inc.於2018年12月6日在特拉華州註冊成立,是一家臨床階段生物製藥公司,專註於為自身免疫性疾病患者提供正常生活。

董事

名稱
職位
Peter Salzmann
Chief Executive Officer,Director
Frank M. Torti
Director,Executive Chairperson of the Board
Andrew Fromkin
Director
Atul Pande
Director
Douglas Hughes
Director
Eric Venker
Director
George Migausky
Director

股東

名稱
職位
Peter Salzmann
Chief Executive Officer,Director
Eva Renee Barnett
Chief Financial Officer
Jay S. Stout
Chief Technology Officer
Julia G. Butchko
Chief Development Officer
Mark S. Levine
Chief Legal Officer and Corporate Secretary
William L. Macias
Chief Medical Officer